Nexturastat A - CAS 1403783-31-2
Catalog number:
1403783-31-2
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
HDAC
Description:
Nexturastat A is an aryl urea derivative that acts as a potent and highly selective inhibitor of histone deacetylase 6 (HDAC6) (IC50= 5.02 +/- 0.60 nM). Nexturastat A possesses antiproliferative effects against melanoma cells. Histone deacetylases (HDACs) mediate regulation of gene expression via changes in nucleosome conformation. Dysregulation of histone acetylation can lead to the development of cancers. There is renewed interest in capitalizing new breakthroughs in epigenetic research to address oncology therapy.
Publictions citing BOC Sciences Products
  • >> More
Purity:
0.98
Appearance:
white solid powder
Synonyms:
Nexturastat A
MSDS:
Inquire
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HDAC Products


CAS 149647-78-9 Vorinostat

Vorinostat
(CAS: 149647-78-9)

Vorinostat (suberoylanilide hydroxamic acid, SAHA) is an HDAC inhibitor with IC50 of ~10 nM.

CAS 151720-43-3 Oxamflatin

Oxamflatin
(CAS: 151720-43-3)

Oxamflatin, also known as Metacept-3, an aromatic sulfonamide derivative, is a cell-permeable, potent HDAC inhibitor (IC50= 15.7 nM) with antitumor effect.

CAS 497833-27-9 Givinostat

Givinostat
(CAS: 497833-27-9)

Givinostat (INN) or gavinostat, aslo known as ITF2357,  is a histone deacetylase inhibitor with potential anti-inflammatory, anti-angiogenic, and antineoplastic...

CAS 1403783-31-2 Nexturastat A

Nexturastat A
(CAS: 1403783-31-2)

Nexturastat A is an aryl urea derivative that acts as a potent and highly selective inhibitor of histone deacetylase 6 (HDAC6) (IC50= 5.02 +/- 0.60 nM). Nextura...

CAS 929016-96-6 Pracinostat

Pracinostat
(CAS: 929016-96-6)

Pracinostat (SB939) is an orally bioavailable, small-molecule histone deacetylase (HDAC) inhibitor with potential antineoplastic activity. Pracinostat inhibits ...

CAS 1069-66-5 Valproic acid sodium salt (Sodium valproate)

Valproic acid sodium salt (Sodium valpro
(CAS: 1069-66-5)

Valproic acid is a HDAC inhibitor by selectively inducing proteasomal degradation of HDAC2, used in the treatment of epilepsy, bipolar disorder and prevention o...

CAS 287383-59-9 Scriptaid

Scriptaid
(CAS: 287383-59-9)

Scriptaid is an inhibitor of HDAC. It shows a greater effect on acetylated H4 than H3.

CAS 732302-99-7 Givinostat hydrochloride monohydrate

Givinostat hydrochloride monohydrate
(CAS: 732302-99-7)

Givinostat, also known as ITF2357, is an orally active HDAC inhibitor (IC50= 198 and 157 nM for HDAC1 and HDAC3, respectively), with potential anti-inflammatory...

CAS 1186222-89-8 4SC-202

4SC-202
(CAS: 1186222-89-8)

4SC-202 is an orally bioavailable benzamide and inhibitor of human class I histone deacetylases (HDACs) isoenzymes 1, 2 and 3, with potential antineoplastic act...

CAS 1418033-25-6 LMK-235

LMK-235
(CAS: 1418033-25-6)

LMK-235 is a selective histone deacetylase (HDAC) 4 and HDAC5 inhibitor. LMK-235 demonstrates activity against chemoresistant cancer cell lines in an MTT assa...

UF010
(CAS: 537672-41-6)

UF-010 is a Class I HDAC inhibitor, inhibiting proliferation of a range of cancer cell lines.

CAS 1622921-15-6 Remodelin

Remodelin
(CAS: 1622921-15-6)

Remodelin, via inhibition of NAT10, mediates nuclear shape rescue of LMNA depleted cells by microtubule reorganization, and improves nuclear shape and fitness o...

CAS 251456-60-7 M344

M344
(CAS: 251456-60-7)

M344 is a potent HDAC inhibitor, which can also induced expression of the pro-apoptotic genes, Puma and Bax, together with the morphological features of apoptos...

CAS 404950-80-7 Panobinostat

Panobinostat
(CAS: 404950-80-7)

Panobinostat is a cinnamic hydroxamic acid analogue with potential antineoplastic activity. Panobinostat selectively inhibits histone deacetylase (HDAC), induci...

HDAC-IN-1
(CAS: 1239610-44-6)

HDAC-IN-1, an analogue of MC 1568, is a Iia HDACs inhibitor that could probably influence myogenesis and adipogenesis.

NCC-149
(CAS: 1316652-41-1)

NCC149 is a potent and selective histone deacetylase 8 (HDAC8) inhibitor.

CAS 99-66-1 Valproic acid

Valproic acid
(CAS: 99-66-1)

Valproic acid is an inhibitor of histone deacetylase (HDAC) inhibitor, which has an anticancer effect. It is a branched short-chain fatty acid. It is previously...

CAS 20554-84-1 (-)-Parthenolide

(-)-Parthenolide
(CAS: 20554-84-1)

(-)-Parthenolide is a sesquiterpene lactone which occurs naturally in the plant feverfew(Tanacetum parthenium) and also promotes the ubiquitination of MDM2 and ...

CAS 875320-29-9 Quisinostat

Quisinostat
(CAS: 875320-29-9)

Quisinostat, also known as JNJ-26481585, is an orally bioavailable, second-generation, hydroxamic acid-based inhibitor of histone deacetylase (HDAC) with potent...

Tinostamustine Hydrochloride
(CAS: 1793059-58-1)

The hydrochloride salt form of Tinostamustine, a benzimidazol derivative, has been found to be a HDAC inhibitor and could probably be effective against sorts of...

Chemical Structure

CAS 1403783-31-2 Nexturastat A

Quick Inquiry

Verification code

Featured Items